Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Go back to Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update| (NYSE: LCTX) | Delayed: 1.01 -0.02 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $ | |||
| Open | $1.02 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 371,151 | |||||
| (NYSE: LCTX) | Delayed: 1.01 -0.02 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $ | |||
| Open | $1.02 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 371,151 | |||||
